This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Service Corporation's (SCI) Q2 Earnings Top Estimates, View Raised
by Zacks Equity Research
Service Corporation's (SCI) second-quarter 2021 results reflect solid earnings and sales, on strength in comparable preneed cemetery sales production and comparable preneed funeral sales production.
Hershey's (HSY) Q2 Earnings Surpass Estimates, Sales Up Y/Y
by Zacks Equity Research
Hershey's (HSY) second-quarter 2021 results reflect higher sales and earnings on strength across North America as well as International and Other unit. Management raises 2021 net sales view.
Pilgrim's Pride (PPC) Q2 Earnings Top Estimates, Sales Up Y/Y
by Zacks Equity Research
Pilgrim's Pride's (PPC) second-quarter 2021 results reflect higher sales and earnings on strength across Mexico, the U.K. and Europe as well as the U.S. operations.
Medifast (MED) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Medifast (MED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mondelez (MDLZ) Q2 Earnings Match Estimates, Revenues Beat
by Vrishali Bagree
Mondelez International's (MDLZ) second-quarter 2021 results reflect a rise in earnings and sales. A solid first-half performance led to a raised organic revenue growth view, though high costs are a concern.
Clorox (CLX) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Elevated manufacturing and logistics costs might have hurt Clorox's (CLX) bottom line in fourth-quarter fiscal 2021. Nonetheless, its IGNITE strategy and cost-saving initiatives are encouraging.
Freshpet (FRPT) to Post Q2 Earnings: What Awaits the Stock?
by Zacks Equity Research
Freshpet's (FRPT) second-quarter performance is likely to have gained from strong consumption trends. However, rising freight and beef costs are a concern.
Have Faith in DuPont Analysis: Buy 5 Top-Ranked Stocks
by Sanghamitra Saha
DuPont technique helps investors to analyze basic ROE at an advanced level. Bet on these five stocks.
Why Medifast (MED) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Medifast (MED) have what it takes? Let's find out.
Lamb Weston (LW) Q4 Earnings & Sales Top Estimates, Rise Y/Y
by Zacks Equity Research
Lamb Weston's (LW) fourth-quarter fiscal 2021 results reflect higher earnings and sales. Management expects continued demand recovery, though cost inflation and disrupted supply chain are concerning.
Factors Setting the Tone for Procter & Gamble's (PG) Q4 Earnings
by Zacks Equity Research
Although cost and currency woes remain concerns, Procter & Gamble's (PG) Q4 results are likely to have gained from continued demand for cleaning products as well as productivity and cost-saving plans.
Things You Need to Know Before Colgate's (CL) Q2 Earnings
by Zacks Equity Research
Strong demand, robust pricing, productivity gains and digital growth are likely to have aided Colgate (CL) in Q2. Elevated advertising, logistics and raw-material expenses remain concerns.
Hershey (HSY) Gears Up to Report Q2 Earnings: What to Expect
by Zacks Equity Research
Hershey's (HSY) second-quarter 2021 results are likely to reflect a rebound in the away-from-home business on higher consumer mobility. However, higher advertising expense may have been a concern.
Church & Dwight (CHD) Queued for Q2 Earnings: Things to Note
by Zacks Equity Research
Church & Dwight's (CHD) second-quarter 2021 results are likely to reflect solid demand for household and personal care products, though escalated costs have been a concern.
Altria (MO) Lined Up for Q2 Earnings: Key Things to Note
by Zacks Equity Research
Altria's (MO) second-quarter 2021 results are likely to reflect solid pricing power and strength in oral tobacco products.
Factors Likely to Influence Keurig Dr Pepper's (KDP) Q2 Earnings
by Zacks Equity Research
Improved at-home penetration and market share gains across the portfolio are likely to have aided Keurig Dr Pepper (KDP) in Q2. Headwinds in the away-from-home channel and currency woes are concerns.
Know How AB InBev (BUD) is Positioned Ahead of Q2 Earnings
by Zacks Equity Research
AB InBev (BUD) is expected to have gained from strength in premium brands, e-commerce and its unique commercial strategy in Q2. Cost headwinds are likely to have hurt.
Molson Coors (TAP) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Revitalization plan, premiumization, beyond beer expansion and omni-channel investment are likely to have aided Molson Coors (TAP) in Q2. Higher marketing spends and COGS are likely to have hurt.
Kimberly-Clark (KMB) Cuts 2021 View on Q2 Earnings & Sales Miss
by Zacks Equity Research
Kimberly-Clark's (KMB) second-quarter 2021 results reflect lower earnings due to increased input costs. Management cuts 2021 view for sales, earnings and adjusted operating profit.
Lamb Weston (LW) Expands French Fry Capacity to Fuel Growth
by Zacks Equity Research
Lamb Weston (LW) is expanding french fry processing capacity at its existing American Falls, ID facility. Management declares quarterly dividend.
Pilgrim's Pride (PPC) Queued for Q2 Earnings: Things to Note
by Zacks Equity Research
Pilgrim's Pride's (PPC) second-quarter 2021 results are likely to reflect gains from U.S. foodservice recovery and higher online sales, though escalated costs are concerning.
4 Reasons Why The J.M. Smucker (SJM) Stock Appears Promising
by Zacks Equity Research
The J.M. Smucker (SJM) is benefiting from its prudent pricing efforts, brand strength and solid digital sales. The company's shareholder-friendly moves are also worth noting.
Service Corporation (SCI) Queued for Q2 Earnings: Things to Note
by Zacks Equity Research
Service Corporation's (SCI) second-quarter results are likely to reflect higher revenues from pandemic-led increased burials and funeral services performed, along with gains from solid cost control.
Mondelez (MDLZ) to Report Q2 Earnings: What Should You Expect?
by Zacks Equity Research
Mondelez's (MDLZ) second-quarter 2021 performance is likely to reflect gains from continued demand for snacks and prudent buyouts. However, COVID-19 costs are a concern.
How to Boost Your Portfolio with Top Consumer Staples Stocks Set to Beat Earnings
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.